Doxycycline Hyclate Tablet, Delayed Release shortage
To Be Discontinued 2 presentations · 1 manufacturers · first FDA posting 2026-07-30 · last update 2026-07-30
Manufacturers: Teva Pharmaceuticals USA, Inc.
Stated reasons (per FDA): Not stated
Presentations
| Presentation | Manufacturer | Status | Reason | Notes (FDA) | Dates |
|---|---|---|---|---|---|
| Doxycycline Hyclate, Tablet, Delayed Release, 50 mg (NDC 0591-4550-22) | Teva Pharmaceuticals USA, Inc. | To Be Discontinued | — | Discontinuation of the manufacture of the drug | Posted 07/30/2026 Updated 07/30/2026 Discontinued 07/30/2026 |
| Doxycycline Hyclate, Tablet, Delayed Release, 200 mg (NDC 0591-4575-60) | Teva Pharmaceuticals USA, Inc. | To Be Discontinued | — | Discontinuation of the manufacture of the drug | Posted 07/30/2026 Updated 07/30/2026 Discontinued 07/30/2026 |
Get the weekly shortage roundup: a free email of FDA shortage changes (open form)